Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase

Journal of Molecular Biology

Volumn 264, Issue 4, 1996, Pages 650-666

  Burke, Donald H ^a   Scates, Lori ^a   Andrews, Katy ^a   Gold, Larry ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b GILEAD SCIENCES   (United States)

Author keywords

Nucleic acid structure; Reverse transcriptase; RNA pseudoknots; RNA protein interactions; SELEX

Indexed keywords

DNA; DOUBLE STRANDED DNA; NUCLEOTIDE; RNA; RNA DIRECTED DNA POLYMERASE; VIRUS ENZYME;

ARTICLE; CONTROLLED STUDY; DRUG TARGETING; GEL ELECTROPHORESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; RNA BINDING; RNA SEQUENCE; RNA STRUCTURE;

EID: 0030582678     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1996.0667     Document Type: Article

References (37)

1. Aiyar, A., Ge, Z. & Leis, J. (1994). A specific orientation of RNA secondary structures is required for initiation of reverse transcription. J. Virol. 68, 611-618.
2. Arnold, E., Ding, J., Hughes, S. H. & Hostomsky, Z. (1995). Structures of DNA and RNA polymerases and their interactions with nucleic acid substrates. Curr. Opin. Struct. Biol. 5, 27-38.
3. Bartel, D. P. & Szostak, J. W. (1993). Isolation of new ribozymes from a large pool of random sequences. Science, 261, 1411-1418.
4. Bilello, J. A., Bilello, P. A., Kort, J. J., Dudley, M. N., Leonard, J. & Drusano, G. L. (1995). Efficacy of constant infusion of A-77003, an inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease, in limiting acute HIV-1 infection in vitro. Antiomicrob. Agents Chemother. 39, 2523-2527.
5. Burgstaller, P. & Famulok, M. (1994). Isolation of RNA aptamers for biological cofactors by in vitro selection. Angewandte Chemie-Int. Ed. English, 33, 1084-1087.
6. Chen, H. & Gold, L. (1994). Selection of high-affinity RNA ligands to reverse transcriptases: inhibition of cDNA synthesis and RNase H activity. Biochemistry, 33, 8746-8756.
7. Chen, H., McBroom, D. C., Zhu, Y.-Q., North, T. & Gold, L. (1996). Inhibitory RNA ligands to feline immunodeficiency virus reverse transcriptase. Biochemistry, 35, 6923-6930.
8. Chen, X., Chamorro, M., Lee, S. I., Shen, L. X., Hinesm, J. V., Tinoco, I. J., Jr & Varmus, H. E. (1995). Structural and functional studies of retroviral RNA pseudoknots involved in ribosomal frameshifting: nucleotides at the junction of the two stems are important for efficient ribosomal frameshifting. EMBO J. 14, 842-852.
9. Ding, J., Das, K., Moereels, H., Koymans, L., Andries, K., Janssen, P. A., Hughes, S. H. & Arnold, E. (1995). Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse non-nucleoside inhibitors. Nature Struct. Biol. 2, 407-415.
10. Draper, D. E. (1993). Protein-DNA complexes: the cost of recognition. Proc. Natl Acad. Sci. USA, 90, 7429-7430.
11. Gotte, M., Fackler, S., Hermann, T., Perola, E., Cellai, L., Gross, H. J., Le Grice, S. F. & Heumann, H. (1995). HIV-1 reverse transcriptase-associated RNase H cleaves RNA/RNA in arrested complexes: implications for the mechanism by which RNase H discriminates between RNA and RNA/DNA. EMBO J. 14, 833-841.
12. Green, L., MacDougal-Waugh, S., Binkley, J. P., Hostomska, Z., Hostomsky, Z. & Tuerk, C. (1995). Comprehensive chemical modification interference and nucleotide substitution analysis of an RNA pseudoknot inhibitor to HIV-1 reverse transcriptase. J. Mol. Biol. 247, 60-68.
13. Irvine, D., Tuerk, C. & Gold, L. (1991). SELEXION -Systematic evolution of ligands by exponential enrichment with integrated optimization by non-linear analysis. J. Mol. Biol. 222, 739-761.
14. Isel, C., Ehresmann, C., Keith, G., Ehresmann, B. & Marquet, R. (1995). Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA(3Lys) (template/primer). J. Mol. Biol. 247, 236-250.
15. Iversen, A. K., Shafer, R. W., Wehrly, K., Winters, M. A., Mullins, J. I., Chesebro, B. & Merigan, T. C. (1996). Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy. J. Virol. 70, 1086-1090.
16. Jacobo-Molina, A., Ding, J., Nanni, R. G., Clark, A. D. J., Lu, X., Tantillo, C., Williams, R. L., Kamer, G., Ferris, A. L., Clark, P., Hizi, A., Hughes, S. H. & Arnold, E. (1993). Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc. Natl Acad. Sci. USA, 90, 6320-6324.
17. Jager, J., Smerdon, S. J., Wang, J., Boisvert, D. C. & Steitz, T. A. (1994). Comparison of three different crystal forms shows HIV-1 reverse transcriptase displays an internal swivel motion. Structure, 2, 869-876.
18. Jungheim, L. N., Shepherd, T. A., Baxter, A. J., Burgess, J., Hatch, S. D., Lubbehusen, P., Wiskerchen, M. & Muesing, M. A. (1996). Potent human immunodeficiency virus type 1 protease inhibitors that utilize noncoded D-amino acids as P2/P3 ligands. J. Med. Chem. 39, 96-108.
19. Kang, I. & Wang, J. H. (1994). Design of structure-based reverse transcriptase inhibitors. J. Biol. Chem. 269, 12024-12031.
20. Kang, H., Hines, J. V. & Tinoco, I., Jr (1996) Conformation of a non-frameshifting RNA pseudoknot from mouse mammary tumor virus. J. Mol. Biol. 259, 135-147.
21. Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A. & Steitz, T. A. (1992). Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science, 256, 1783-1790.
22. Lesser, D. R., Kurpiewski, M. R., Waters, T., Connolly, B. A. & Jen-Jacobson, L. (1993). Facilitated distortion of the DNA site enhances EcoRI endonuclease-DNA recognition. Proc. Natl Acad. Sci. USA, 90, 7548-7552.
23. Markowitz, M., Saag, M. Powderly, W. G., Hurley, A. M., Hsu, A. Z., Valdes, J. M., Henry, D., Sattler, F., La Marca, A., Leonard, J. M. et al. (1995). A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. New Eng. J. Med. 333, 1534-1539.
24. Maruenda, H. & Johnson, F. (1995). Design and synthesis of novel inhibitors of HIV-1 reverse transcriptase. J. Med. Chem. 38, 2145-2151.
25. Milligan, J. F. & Uhlenbeck, O. C. (1989). Synthesis of small RNAs using T7 RNA polymerase. Methods Enzymol. 180, 51-62.
26. Mishima, Y. & Steitz, J. A. (1995). Site-specific crosslinking of 4-thiouridine-modified human tRNA(3Lys) to reverse transcriptase from human immunodeficiency virus type I. EMBO J. 14, 2679-2687.
27. Philippe, C., Benard, L., Portier, C., Westhof, E., Ehresmann, B. & Ehresmann, C. (1995). Molecular dissection of the pseudoknot governing the translational regulation of Escherichia coli ribosomal protein S15. Nucl. Acids Res. 23, 18-28.
28. Pullen, K. A., Rattray, A. J. & Champoux, J. J. (1993). The sequence features important for plus strand priming by human immunodeficiency virus type 1 reverse transcriptase. J. Biol. Chem. 268, 6221-6227.
29. Ren, J., Esnouf, R., Hopkins, A., Ross, C., Jones, Y., Stammers, D. & Stuart, D. (1995). The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design. Structure, 3, 915-926.
30. Sassanfar, M. & Szostak, J. W. (1993). An RNA motif that binds ATP. Nature, 364, 550-553.
31. Schneider, D. J., Feigon, J., Hostomsky, Z. & Gold, L. (1995). High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. Biochemistry, 34, 9599-9610.
32. Setlik, R. F., Meyer, D. J., Shibata, M., Roskwitalski, R., Ornstein, R. L. & Rein, R. (1994). A full-coordinate model of the polymerase domain of HIV-1 reverse transcriptase and its interaction with a nucleic acid substrate. J. Biomol. Struct. Dynam. 12, 37-60.
33. Shen, L. X. & Tinoco, I. J., Jr (1995). The structure of an RNA pseudoknot that causes efficient frameshifting in mouse mammary tumor virus. J. Mol. Biol. 247, 963-978.
34. Tuerk, C. & Gold, L. (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science, 249, 505-510.
35. Tuerk, C., MacDougal, S. & Gold, L. (1992). RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl Acad. Sci. USA, 89, 6988-6992.
36. Unge, T., Knight, S., Bhikhabhai, R., Lovgren, S., Dauter, Z., Wilson, K. & Strandberg, B. (1994). 2.2 Å resolution structure of the amino-terminal half of HIV-1 reverse transcriptase (fingers and palm subdomains). Structure, 2, 953-961.
37. Wyatt, P. G., Bethell, R. C., Cammack, N., Charon, D., Dodic, N., Dumaitre, B., Evans, D. N., Green, D. V., Hopewell, P. L., Humber, D. C. et al. (1995). Benzophenone derivatives: a novel series of potent and selective inhibitors of human immunodeficiency virus type 1 reverse transcriptase. J. Med. Chem. 38, 1657-1665.